Does including informal care in economic evaluations matter? A systematic review of inclusion and impact of informal care in cost-effectiveness studies (Q38260217)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Does including informal care in economic evaluations matter? A systematic review of inclusion and impact of informal care in cost-effectiveness studies	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

1 reference

Europe PubMed Central

Does including informal care in economic evaluations matter? A systematic review of inclusion and impact of informal care in cost-effectiveness studies (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

systematic review

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25315368%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Jocé Papenburg

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25315368%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Job van Exel

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25315368%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 February 2015

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25315368%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

33

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25315368%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25315368%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

123-135

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25315368%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Implications of spillover effects within the family for medical cost-effectiveness analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

Social networks and collateral health effects

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

Caring for and caring about: disentangling the caregiver effect and the family effect.

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

How to include informal care in economic evaluations

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

Caregiving as a risk factor for mortality: the Caregiver Health Effects Study

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

Objective burden, resources, and other stressors among informal cancer caregivers: a hidden quality issue?

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

Incorporating carer effects into economic evaluation.

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

Is the societal approach wide enough to include relatives? Incorporating relatives' costs and effects in a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

QALYs and carers.

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

The inclusion of informal care in applied economic evaluation: a review

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

Caregiver-burden in parkinson's disease is closely associated with psychiatric symptoms, falls, and disability.

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

Societal cost of rheumatoid arthritis patients in the US.

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

Management of patients with malignant bowel obstruction and stage IV colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

Managing cancer pain at the end of life with multiple strong opioids: a population-based retrospective cohort study in primary care.

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

Measuring costs in cost-utility analyses. Variations in the literature

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

Cost-effectiveness of memantine in moderate and severe Alzheimer's disease in Norway.

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

Cost-effectiveness of one year dementia follow-up care by memory clinics or general practitioners: economic evaluation of a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

An economic evaluation of early assessment for Alzheimer's disease in the United Kingdom

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

Cost-effectiveness of magnetic resonance imaging with a new contrast agent for the early diagnosis of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

Cost-utility analysis of treatment strategies in patients with recent-onset rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

Cost-effectiveness of real-world infliximab use in patients with rheumatoid arthritis in Sweden

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

Cost‐effectiveness of biologics in polyarticular‐course juvenile idiopathic arthritis patients unresponsive to disease‐modifying antirheumatic drugs

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

Cost-effectiveness of etanercept treatment in early active rheumatoid arthritis followed by dose adjustment

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

Modeling the cost-effectiveness of treatment of rheumatoid arthritis with rituximab using registry data from Southern Sweden

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

Evaluating the cost effectiveness of donepezil in the treatment of Alzheimer's disease in Germany using discrete event simulation

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

REMCARE: reminiscence groups for people with dementia and their family caregivers - effectiveness and cost-effectiveness pragmatic multicentre randomised trial.

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine.

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

Assessing the cost-effectiveness of the rivastigmine transdermal patch for Alzheimer's disease in the UK using MMSE- and ADL-based models

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

Cost effectiveness of rasagiline and pramipexole as treatment strategies in early Parkinson's disease in the UK setting: an economic Markov model evaluation

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

Modeling the cost-effectiveness of galantamine for mild to moderately severe Alzheimer's disease in Korea

1 reference

https://api.crossref.org/works/10.1007%2FS40273-014-0218-Y

21 January 2018

The cost-effectiveness of TNF-inhibitors for the treatment of rheumatoid arthritis in Swedish clinical practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/25315368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of a health intervention program with risk reductions for getting demented: results of a Markov model in a Swedish/Finnish setting

1 reference

https://pubmed.ncbi.nlm.nih.gov/25315368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25315368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Too important to ignore: informal caregivers and other significant others

1 reference

https://pubmed.ncbi.nlm.nih.gov/25315368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alzheimer's dementia: budget impact and cost-utility analysis of a combination treatment of a cholinesterase inhibitor and memantine in Switzerland

1 reference

https://pubmed.ncbi.nlm.nih.gov/25315368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Juggling work and elder caregiving: work-life balance for aging American workers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25315368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health effects in significant others: separating family and care-giving effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/25315368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of memantine in combination with acetylcholinesterase inhibitors on admission of patients with Alzheimer's disease to nursing homes: cost-effectiveness analysis in France

1 reference

https://pubmed.ncbi.nlm.nih.gov/25315368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An overview of methods and applications to value informal care in economic evaluations of healthcare

1 reference

https://pubmed.ncbi.nlm.nih.gov/25315368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activities of daily living and quality of life in Alzheimer disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25315368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Burden of caregiving: evidence of objective burden, subjective burden, and quality of life impacts on informal caregivers of patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25315368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Caregivers of Alzheimer's patients and factors influencing institutionalization of loved ones: some considerations on existing literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/25315368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer's disease in the Netherlands

1 reference

https://pubmed.ncbi.nlm.nih.gov/25315368

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S40273-014-0218-Y

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25315368%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25315368%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38260217&oldid=2201485056"